Form 4 for IMNM Immunome Inc.
Accepted 2025-12-30 00:00:00 ET · period of report 2025-12-30 · accession 0001167496-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-12-30 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $21.15 | +4,729 | 665.3K | +0.7% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-30 | P | A | 4,729 | $21.15 | 665,254 | D | — | — |